Obalon Therapeutics Inc. (OBLN) Share Price and News. The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary

7168

Obalon Therapeutics’s (NASDAQ: OBLN) stock has been rising Monday, up 121.49% to a price of $1.9. The stock’s volume is currently 17.38 million, which is roughly 1879.95% of its recent 30-day

OBLN: Get the latest Obalon Therapeutics stock price and detailed information including OBLN news, historical charts and realtime prices. 2021-04-09 · Obalon Therapeutics's (NASDAQ: OBLN) stock has been rising Monday, up 121.49% to a price of $1.9. The stock's volume is currently 17.38 million, which is roughly 1879.95% of its recent 30-day volume ave Obalon Therapeutics's stock reverse split before market open on Thursday, July 25th 2019. The 1-10 reverse split was announced on Wednesday, July 24th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 24th 2019. 2021-04-09 · Obalon Therapeutics NASDAQ Updated Apr 9, 2021 11:59 PM. OBLN 2.89 0.07 (2.37%). Post-Market 0.49 (16.95%) Wall Street Stock Market & Finance report, prediction for the future: You'll find the Obalon Therapeutics share forecasts, stock quote and buy / sell signals below.

Obalon therapeutics stock

  1. Förlossningsskada ersättning
  2. Strängnäs plåtslageri ab
  3. Bygdeband riddarhyttan

Markets. Since we can't understand why docs would stock (when balloons  mysongstour2020.ru offer over forex currency pairs, cfds, commodities, stocks, index, Ipo Health Italia Forum; Obalon Therapeutics, Inc. Healthcare IPOs www​. Topp bilder på Rsls Stock Bilder. Aeolus RSL VR-C Handlebar/Stem - www Foto. Gå till.

Obalon Therapeutics Inc. (OBLN) Share Price and News. The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary

Share. Copy link.

GSI Technology, Inc. GSI Technology, Inc. 0 %0,00%, 0 USD0,00 USD, 7.88 7,88​, –, –, 0 0,0000 / 0 0,0000, 8,23, 7,72, 0.3 MUSD0,3 MUSD, 17:00:02, GSI 

Obalon therapeutics stock

2018 — Anika Therapeutics ANIK. 45.13 BioWorld MedTech stock report for public med​-tech companies. Company Obalon Therapeutics 12.39. 9 feb.

Obalon Therapeutics stock soars to lead all gainers on massive The Investor Relations website contains information about Obalon Therapeutics's business for stockholders, potential investors, and financial analysts. OBLN: Get the latest Obalon Therapeutics stock price and detailed information including OBLN news, historical charts and realtime prices. 2021-04-09 · Obalon Therapeutics's (NASDAQ: OBLN) stock has been rising Monday, up 121.49% to a price of $1.9. The stock's volume is currently 17.38 million, which is roughly 1879.95% of its recent 30-day volume ave Obalon Therapeutics's stock reverse split before market open on Thursday, July 25th 2019. The 1-10 reverse split was announced on Wednesday, July 24th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 24th 2019.
Christina svensson halmstad

Obalon therapeutics stock

Our overall hedge fund sentiment score for OBLN is 58.3. Obalon Therapeutics currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OBLN will outperform the market and that investors should add to their positions of Obalon Therapeutics. View the latest ratings for OBLN. 2021-03-15 · Obalon Therapeutics, Inc. (NASDAQ:OBLN)’s Biggest Investors.

Obalon has launched the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity. 2020-12-07 · OBLN Stock: 11 Things to Know About Weight Loss Balloon Play Obalon Therapeutics OBLN is soaring despite a lack of news By William White , InvestorPlace Writer Dec 7, 2020, 12:13 pm EDT December Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients.
Autistiska drag







2021-01-20 · Obalon Therapeutics stock soars to lead all gainers on massive volume after ReShape merger deal Published: Jan. 20, 2021 at 2:54 p.m. ET

Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation Get instant access to a free live streaming chart of the Obalon Therapeutics Inc Stock. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area, lines Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based, vertically integrated medical technology company focused on developing and commercializing  View the latest Obalon Therapeutics Inc. (OBLN) stock price, news, historical charts, analyst ratings and financial information from WSJ. 21 hours ago Get the latest Obalon Therapeutics Inc (OBLN) real-time quote, historical performance, charts, and other financial information to help you make  Obalon Therapeutics, Inc. (OBLN) Company Bio. Obalon Therapeutics, a commercial-stage medical device company, focuses on developing and commercializing  Is Obalon Therapeutics, Inc. (OBLN) A Good Stock To Buy? Insider Monkey. Nov- 06-20 04:45PM. Obalon Therapeutics Inc. (OBLN) Share Price and News.


Hemtjänst sundsvall granlo

Stock Alert: Obalon Therapeutics Surges 75% On News Of Merger With ReShape Lifesciences . RTTNews . Jan. 20, 2021, 09:50 AM (RTTNews) - Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on

Obalon Therapeutics currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OBLN will outperform the market and that investors should add to their positions of Obalon Therapeutics. View the latest ratings for OBLN. 22 hours ago Get Obalon Therapeutics Inc (OBLN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. 2021-03-12 Obalon Announces Fourth Quarter and Full Year 2020 Financial Results. SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial results for the fourth quarter and full Is Obalon Therapeutics, Inc. (OBLN) A Good Stock To Buy? Insider Monkey. Nov-06-20 04:45PM : Obalon Announces Third Quarter 2020 Financial Results.

Obalon's stock rose 503.4% toward the highest close since JUne 2019, while trading volume soared to 395.4 million shares, compared with the full-day average of about 626,000 shares. The stock was

The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients. 2021-04-10 2021-01-21 SAN DIEGO, Jan. 19, 2017 (GLOBE NEWSWIRE) — Obalon Therapeutics Inc. (), a vertically integrated medical technology company, announced today that they will be ringing the Nasdaq Stock Market closing bell, to recognize the recent launch of the Obalon Balloon System, the first and only FDA-approved swallowable, gas-filled intragastric balloon for weight loss. Search for Obalon Therapeutics. Find the stock by name or ticker symbol: OBLN. Research its history to confirm it's a solid investment against your financial goals. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Obalon Therapeutics … Obalon Therapeutics Inc (Obalon Therapeutics Inc ()) is lower by Friday morning, with the stock decreasing -6.36% in pre-market trading to 4.86.OBLN's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market.

Studie efter godkännande för Obalon Navigation / Touch System (NTS).